Therapeutic Agent
OwnerTatsuji Enoki, Yoko Kudo +4inventors
InventorsTatsuji Enoki, Yoko Kudo, Katsumi Sugiyama, Hiromu Ohnogi, Hiroaki Sagawa, Ikunoshin Kato
Life of this patent
Estimating the term…
Abstract
A therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient a processed product derived from Peucedanum japonicum.
Claims16
A therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient a processed product derived from Peucedanum japonicum.
An anti-foaming agent for a cell, characterized in that the anti-foaming agent comprises as an effective ingredient a processed product derived from Peucedanum japonicum.
An inhibitory agent for acyl-CoA cholesterol acyltransferase, characterized in that the inhibitory agent comprises as an effective ingredient a processed product derived from Peucedanum japonicum.
A food or feed for anti-foaming for a cell and/or an inhibition for acyl-CoA cholesterol acyltransferase, characterized in that the food or feed comprises as an effective ingredient a processed product derived from Peucedanum japonicum.
A therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient one or more kinds selected from the group consisting of 3′-acetoxy-4′-senecioyloxy-3′,4′-dihydroseselin, a derivative thereof, and pharmaceutically acceptable salts thereof.
An anti-foaming agent for a cell, characterized in that the anti-foaming agent comprises as an effective ingredient one or more kinds selected from the group consisting of 3′-acetoxy-4′-senecioyloxy-3′,4′-dihydroseselin, a derivative thereof, and pharmaceutically acceptable salts thereof.
An inhibitory agent for acyl-CoA cholesterol acyltransferase, characterized in that the inhibitory agent comprises as an effective ingredient one or more kinds selected from the group consisting of 3′-acetoxy-4′-senecioyloxy-3′,4′-dihydroseselin, a derivative thereof, and pharmaceutically acceptable salts thereof.
A food or feed for anti-foaming for a cell and/or an inhibition for acyl-CoA cholesterol acyltransferase, characterized in that the food or feed comprises as an effective ingredient one or more kinds selected from the group consisting of 3′-acetoxy-4′-senecioyloxy-3′,4′-dihydroseselin, a derivative thereof, and pharmaceutically acceptable salts thereof.
A method of treating or preventing a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, comprising administering to a subject an effective amount of a processed product derived from Peucedanum japonicum.
Use of a processed product derived from Peucedanum japonicum for manufacturing of a therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention.
A method of treating or preventing a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, comprising administering to a subject an effective amount of one or more kinds selected from the group consisting of 3′-acetoxy-4′-senecioyloxy-3′,4′-dihydroseselin, a derivative thereof, and pharmaceutically acceptable salts thereof.
Use of one or more kinds selected from the group consisting of 3′-acetoxy-4′-senecioyloxy-3′,4′-dihydroseselin, a derivative thereof, and pharmaceutically acceptable salts thereof for manufacturing of a therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention.
Dependencies are inferred from the claim text.